Top segments and regional performance

Last year, the company generated 489.33 M USD, the most of which — 491.73 M USD — came from its top-performing segment, Drug Products, compared to 398.20 M USD the previous year. The greatest contribution came from United States, which accounted for 491.73 M USD last year, with 398.20 M USD the year before.